Australian (ASX) Stock Market Forum

RBY - Rockeby Biomed

Jump to new
Bouncing back today. I can't imagine this stock staying around the 2cents mark for too long especially with the bird flu outbreak news we are getting. Cash flow will be an issue but I still see value in this stock. I know not everyone is positive on RBY but I believe the mood will change the question is how long will it take.
 
Ohhh nooo...its on again...best I bend you both over and slap you with a paddle :eek:

Nothing changes and even with a new year we see Fab plastering the RBY board with media articles and rederob spraying his :2twocents about how poxy RBY is...LOL

Ohhh the fun continues.
 
Thought I might spice it up a little.

I'm a holder. In at 2.4c and enjoying this slow up trend to a present price of 2.9c. Looks like it's going to be a bit tricky testing the 3c mark.

Volume is definitely up for the last two weeks. MACD good. With the slow uptrend all we need is a good announcement about another deal and this could break the 3.5c. I'd like to see it hold 3c for a while to prove investor confidence and then see it slowly move off up again. Have a 250,000 share exposure at present.

I know noone else here seems interested in price channel modelling but I like it. I topped up heaps when it came back off the bottom of the channel in late DEC. It was a bit risky but the MACD indicator has been good since. As it's at the top of the current 20day channel I'm not sure what's going to happen but it feels like it will break the channel ceiling and keep going.

Anyone want to T/A this stock / chart?
 

Attachments

  • blt.gif
    blt.gif
    10.5 KB · Views: 129
britishcarfreak said:
Thought I might spice it up a little.

I'm a holder. In at 2.4c and enjoying this slow up trend to a present price of 2.9c. Looks like it's going to be a bit tricky testing the 3c mark.

Volume is definitely up for the last two weeks. MACD good. With the slow uptrend all we need is a good announcement about another deal and this could break the 3.5c. I'd like to see it hold 3c for a while to prove investor confidence and then see it slowly move off up again. Have a 250,000 share exposure at present.

I know noone else here seems interested in price channel modelling but I like it. I topped up heaps when it came back off the bottom of the channel in late DEC. It was a bit risky but the MACD indicator has been good since. As it's at the top of the current 20day channel I'm not sure what's going to happen but it feels like it will break the channel ceiling and keep going.

Anyone want to T/A this stock / chart?
Click to expand...

I like this positive thought on RBY britishcarfreak. I also think 0.03 will be a test. I guess my point about bird flu outbreak in Vietnam it is that it is some potential business for RBY a bit like what happened in Indonesia. I agree another another should make it spike again.Unfortunately RBY seems to work by rising substantially and then falling back to where it was.
 
RBY announce licenses of test for Pre-Eclampsia this morning:

18 January, 2007: Rockeby biomed Ltd (ASX:RBY) is pleased to announce it has entered into a worldwide
licensing agreement to license a blood test to diagnose Pre-eclampsia. This is a common medical
disorder of pregnancy, which is known as pregnancy-induced hypertension . This is subsequent to the test
achieving critical milestones in the first phase of its development.
Rockeby, which has been funding the development of the pre-eclampsia test since August 2005, has
secured the licensing agreement with the Queensland-based developer of the test Dr Victor Voroteliak and
his company Diagnoz Pty Ltd.
Rockeby chief executive Dr Sze Wee Tan said the company would now fund the second round of the
development of the test under a new licensing agreement. This test would also add to the Intellectual
Property library that the Company is acquiring as it develops diagnostic tests for female healthcare needs.
“We have entered into a licensing agreement with Dr Voroteliak to license the pre-eclampsia test in return
for a new round of funding up to July 2007,” Dr Tan said. “Once we have completed the last development
milestone, we can continue to explore external funding for this project, as we have already licensed the
rights to the intellectual property from Dr Voroteliak with this licensing agreement. “
Pre-eclampsia is the most common medical disorder of pregnancy with a reported incidence in the obstetric
literature, affecting at least 5-8% of all pregnancies. It is a rapidly progressive condition characterized by
high blood pressure and the presence of protein in the urine. Swelling, sudden weight gain, headaches and
changes in vision are important symptoms; however, some women with rapidly advancing disease report
few symptoms.
Dr Tan said a patent for the test has been filed with the US Patent Trademark Office.
“This project is also being evaluated by venture capital groups for external funding, once we have reached
the milestones for their investment,” Dr Tan said. “With our new licensing agreement with Dr Voroteliak, we
can then obtain external funding to drive this project forward.”​
 
britishcarfreak said:
RBY announce licenses of test for Pre-Eclampsia this morning:

18 January, 2007: Rockeby biomed Ltd (ASX:RBY) is pleased to announce it has entered into a worldwide
licensing agreement to license a blood test to diagnose Pre-eclampsia. This is a common medical
disorder of pregnancy, which is known as pregnancy-induced hypertension . This is subsequent to the test
achieving critical milestones in the first phase of its development.
Rockeby, which has been funding the development of the pre-eclampsia test since August 2005, has
secured the licensing agreement with the Queensland-based developer of the test Dr Victor Voroteliak and
his company Diagnoz Pty Ltd.
Rockeby chief executive Dr Sze Wee Tan said the company would now fund the second round of the
development of the test under a new licensing agreement. This test would also add to the Intellectual
Property library that the Company is acquiring as it develops diagnostic tests for female healthcare needs.
“We have entered into a licensing agreement with Dr Voroteliak to license the pre-eclampsia test in return
for a new round of funding up to July 2007,” Dr Tan said. “Once we have completed the last development
milestone, we can continue to explore external funding for this project, as we have already licensed the
rights to the intellectual property from Dr Voroteliak with this licensing agreement. “
Pre-eclampsia is the most common medical disorder of pregnancy with a reported incidence in the obstetric
literature, affecting at least 5-8% of all pregnancies. It is a rapidly progressive condition characterized by
high blood pressure and the presence of protein in the urine. Swelling, sudden weight gain, headaches and
changes in vision are important symptoms; however, some women with rapidly advancing disease report
few symptoms.
Dr Tan said a patent for the test has been filed with the US Patent Trademark Office.
“This project is also being evaluated by venture capital groups for external funding, once we have reached
the milestones for their investment,” Dr Tan said. “With our new licensing agreement with Dr Voroteliak, we
can then obtain external funding to drive this project forward.”​
Click to expand...
That should be worth some money. It is probably why RBY is jumping today on big volume.
 
britishcarfreak said:
Thought I might spice it up a little.

I'm a holder. In at 2.4c and enjoying this slow up trend to a present price of 2.9c. Looks like it's going to be a bit tricky testing the 3c mark.

Volume is definitely up for the last two weeks. MACD good. With the slow uptrend all we need is a good announcement about another deal and this could break the 3.5c. I'd like to see it hold 3c for a while to prove investor confidence and then see it slowly move off up again. Have a 250,000 share exposure at present.

I know noone else here seems interested in price channel modelling but I like it. I topped up heaps when it came back off the bottom of the channel in late DEC. It was a bit risky but the MACD indicator has been good since. As it's at the top of the current 20day channel I'm not sure what's going to happen but it feels like it will break the channel ceiling and keep going.

Anyone want to T/A this stock / chart?
Click to expand...
Maybe yesterdays announcement is what we needed to keep it above the 3 cents mark. I guess the problem with this worldwide agreement is that it is a very positive step forward but the share market wants to see some real money deals then rby should rocket up. A bit like when they last announced a sale of their fast bird flu kit to Indonesia.
Also a good thing is that the focus seems to be switching a bit toward biotech companies again that did not do so well last year. :)
 
Today's news:

The following is a summary of Rockeby’s developments during the quarter ended 31 December
2006.

• Receipts from customers equalled $837,000. This represents a 1016% increase when
compared to the previous corresponding quarter.
• Share Purchase Plan successfully raises $1.24 million; Private Placement raises a further
$2.28 million
• Development and working capital requirements provided for remainder of financial year
• Record sales for the quarter with the successful delivery of 191,000 Avian Flu
diagnostics tests to Indonesian partner followed immediately with another tender award
of 19,800 tests
• Rockeby awarded tenders for Avian Flu diagnostics from Jordon and Romania
• Conditional agreement for strategic investment in Chinese company, Beijing Anheal
Laboratories Co Ltd (ANHEAL) will give Rockeby access to world’s largest poultry
market
• German-based AJ-Roboscreen GmbH (AJR) to be Rockeby’s exclusive distributor of
Avian Influenza Virus tests in Germany, Hungary, Bulgaria and Slovenia.​

This should easily prop it up over the 3 cent mark. I hope it helps to explain the fundamentals for non-believers.
 
No disrespect Mr carfreak, but to understand the fundamentals you need to look at the whole picture. Costs went up, 200 million shares issued @ an average 1.7 cents, and sales proceeds don't cover costs yet. If they can keep accelerating the sales, then they'll stand a chance. That's still a BIG if though...
 
Fab said:
From listing to that broadcast it sounds like the second half of 2007 is when rby should start getting some money from the huge China market.
I don't understand how there isn't more people who can see the huge potential of this company
Click to expand...
Not a lot to understand about a dog:
Sit.
Lie down.
Play dead.
Good boy!
 
Fab
Fundamentally - a cot case.
Technically - uninspiring!
Pretty picture:
 

Attachments

  • big.gif
    big.gif
    6.9 KB · Views: 53

Similar threads

kahuna1
All trading needs to cease for 14 days prior to Monday open in Sydney
2 3 4
Replies
75
Views
10K
divs4ever
divs4ever
Top